With an aging population that has been increasing in recent years, the need for the
development of therapeutic approaches for treatment of neurodegenerative disorders (ND) …

Glioblastoma (GBM) is the most common malignant adult brain cancer with no curative
treatment strategy. A significant hurdle in GBM treatment is effective therapeutic delivery to …

Nanogels have come out as a great potential drug delivery platform due to its prominently
high colloidal stability, high drug loading, core-shell structure, good permeation property and …

Silver nanoparticles have a wide range of research, industrial and biomedical applications
that make it essential to develop a low cost and eco-friendly approach with scaling up …

The blood-brain barrier (BBB) is a sophisticated and very selective dynamic interface
composed of endothelial cells expressing enzymes, transport systems, and receptors that …

Neurons and their connecting axons gradually degenerate in neurodegenerative diseases
(NDs), leading to dysfunctionality of the neuronal cells and eventually their death. Drug …

Abstract The World Health Organization (WHO) has declared that neurodegenerative
diseases will be the biggest health issues of the twenty-first century. Among these …

Abstract Background Cerium oxide nanoparticles (CeO 2 NPs) have potential application for
use in biomedical and in various consumer products. However, it is largely unclear whether …

Alzheimer's disease (AD) is a degenerative disease of the central nervous system
characterized by progressive cognitive and memory-related impairment. However, current …

High-density lipoproteins (HDL) are naturally-occurring nanoparticles that are
biocompatible, non-immunogenic and completely biodegradable. These endogenous …